Bizzari Jean-Pierre
CIK 0001630914
Director
Filings
9
Latest Jun 3, 2026
Issuers covered
3
Showing
9 of 9
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 0% | -34.0% | -34.0% | -34.0% | -34.0% |
| 90 days | 1 | 0% | -9.2% | -9.2% | -9.2% | -9.2% |
| 180 days | 1 | 100% | +29.1% | +29.1% | +29.1% | +29.1% |
| 365 days | 1 | 0% | -15.6% | -15.6% | -15.6% | -15.6% |
Issuers
Companies where Bizzari Jean-Pierre has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ADCT | Adc Therapeutics SA | 5 | Jun 3, 2026 |
| APRE | Aprea Therapeutics, Inc. | 2 | Jun 9, 2025 |
| HALO | Halozyme Therapeutics, Inc. | 2 | May 9, 2023 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|